Discontinuation report ABILIFY
| Report ID | 129991 |
| Drug Identification Number | 02322390 |
| Brand name | ABILIFY |
| Common or Proper name | ARIPIPRAZOLE |
| Company Name | OTSUKA PHARMACEUTICAL CO LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ARIPIPRAZOLE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | BLISTER format only |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-04-30 |
| Actual discontinuation date | 2021-04-30 |
| Remaining supply date | 2021-04-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Samples in blister format are available until the discontinuation date. |
| Company comments | ONLY BLISTER (sample) format is discontinued. The bottle format is still available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2021-05-01 | English | Compare |
| v2 | 2020-12-10 | French | Compare |
| v1 | 2020-12-10 | English | Compare |
Showing 1 to 3 of 3